EWJ News 11.82 08/29/2014 05:00:12 Japan Index MSCI Ishares

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Japan Index MSCI Ishares (EWJ) 11.82 $EWJ

Introductory Guide to Japan ETF Investing - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Aug 28, 9:00AM CDT
For investors thinking about Japan ETFs, consider taking a look at these popular ETFs focused on the space.

SmarTrend Watching for Potential Rebound in Shares of iShares MSCI Japan Index Fund After 1.58% Loss
Comtex SmarTrend(R) - Tue Aug 05, 4:32PM CDT
iShares MSCI Japan Index Fund (NYSE:EWJ) traded in a range yesterday that spanned from a low of $11.77 to a high of $11.90. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $11.95 on volume of 29.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

iShares MSCI Japan Index Fund Falls 1.48% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Thu Jul 31, 5:01PM CDT
iShares MSCI Japan Index Fund (NYSE:EWJ) traded in a range yesterday that spanned from a low of $11.99 to a high of $12.09. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $12.15 on volume of 39.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Watch for iShares MSCI Japan Index Fund to Potentially Rebound After Falling 1.48% Yesterday
Comtex SmarTrend(R) - Thu Jul 31, 5:01PM CDT
iShares MSCI Japan Index Fund (NYSE:EWJ) traded in a range yesterday that spanned from a low of $11.99 to a high of $12.09. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $12.15 on volume of 39.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

How Will Japan's New Fiscal Policy Impact Its Assets?
Louie Grint, The Motley Fool - Motley Fool - Fri Jul 11, 4:40PM CDT
The monetary experiments aimed to drag Japan out of two decades of deflation have started having some effects. Unbelievably, the Japanese consumer price index for May jumped 3.4% year over year -- the fastest rate in 32 years. What did the Japanese...

After Yesterday's Decline of 1.73%, iShares MSCI Japan Index Fund Offers Investors Better Value
Comtex SmarTrend(R) - Thu Jul 10, 3:43PM CDT
iShares MSCI Japan Index Fund (NYSE:EWJ) traded in a range yesterday that spanned from a low of $11.84 to a high of $11.95. Yesterday, the shares fell 1.7%, which took the trading range below the 3-day low of $12.02 on volume of 49.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Look for Shares of iShares MSCI Japan Index Fund to Potentially Rebound after Yesterday's 1.73% Sell Off
Comtex SmarTrend(R) - Thu Jul 10, 3:42PM CDT
iShares MSCI Japan Index Fund (NYSE:EWJ) traded in a range yesterday that spanned from a low of $11.84 to a high of $11.95. Yesterday, the shares fell 1.7%, which took the trading range below the 3-day low of $12.02 on volume of 49.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

1 Easy Way to Profit From Abenomics
Ankush Shaw, The Motley Fool - Motley Fool - Tue Jul 08, 6:08PM CDT
Thanks to Japanese Prime Minister Shinzo Abe's policies aimed at reviving growth in the economy, popularly known as "Abenomics," Japanese equity prices soared to record levels las year. However, 2014 has been anything but remarkable for the...

Stock Market Strategists On Defense After Q2 Rise
at Investor's Business Daily - Wed Jul 02, 6:09PM CDT
Despite a flurry of geopolitical turbulence, fund investors enjoyed decent returns in the second quarter of 2014 as the stock market booked a six-quarter winning streak. Investing strategists, however, are positioning themselves defensively in the...

Watch for iShares MSCI Japan Index Fund to Potentially Pullback After Gaining 1.74% Yesterday
Comtex SmarTrend(R) - Tue Jul 01, 4:42PM CDT
iShares MSCI Japan Index Fund (NYSE:EWJ) traded in a range yesterday that spanned from a low of $12.18 to a high of $12.25. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $12.07 on volume of 26.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

SmarTrend Watching for Potential Pullback in Shares of iShares MSCI Japan Index Fund After 1.74% Gain
Comtex SmarTrend(R) - Tue Jul 01, 4:41PM CDT
iShares MSCI Japan Index Fund (NYSE:EWJ) traded in a range yesterday that spanned from a low of $12.18 to a high of $12.25. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $12.07 on volume of 26.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Inside The Top Ranked Japan Hedged Equity ETF - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Jun 26, 9:04AM CDT
If investors are looking for a top ranked Japan hedged equity ETF, consider DBJP.

Japan Stocks Jump, Nikkei Up Nearly 10% Since Mid-May
at Investor's Business Daily - Thu Jun 19, 6:02PM CDT
Just what drove the 1.6% surge by Tokyo's Nikkei 225 index Thursday is up for debate. Some say it was investor reaction to tax reforms and other strategic moves by Prime Minister Shinzo Abe to create a more business-friendly economy. Others say the...

After Yesterday's Rally of 1.35% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Jun 18, 3:54PM CDT
iShares MSCI Japan Index Fund (NYSE:EWJ) traded in a range yesterday that spanned from a low of $11.84 to a high of $12.00. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $11.86 on volume of 37.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

iShares MSCI Japan Index Fund Rises 1.35% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Jun 18, 3:53PM CDT
iShares MSCI Japan Index Fund (NYSE:EWJ) traded in a range yesterday that spanned from a low of $11.84 to a high of $12.00. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $11.86 on volume of 37.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Look for Shares of iShares MSCI Japan Index Fund to Potentially Pullback after Yesterday's 1.45% Rise
Comtex SmarTrend(R) - Thu Mar 27, 3:44PM CDT
iShares MSCI Japan Index Fund (NYSE:EWJ) traded in a range yesterday that spanned from a low of $11.13 to a high of $11.22. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $11.16 on volume of 70.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

iShares MSCI Japan Index Fund Set to Possibly Rebound After Yesterday's Selloff of 1.44%
Comtex SmarTrend(R) - Thu Mar 20, 3:47PM CDT
iShares MSCI Japan Index Fund (NYSE:EWJ) traded in a range yesterday that spanned from a low of $10.86 to a high of $10.96. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $11.02 on volume of 71.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 62

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 299

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 343

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 29

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 123

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 119

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 456

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading

Top 5 Most Recently Viewed Articles

Brazil Potash Secures $75 Million Equity Line for Growth

Updated Category News Views 167

Brazil Potash Secures Key Funding for Autazes Project Brazil Potash Corp. (“Brazil Potash” or the “Company”) (NYSE American: GRO), a prominent player in mineral development focused on potash mining, has recently finalized a significant agreement establishing an equity line of credit (ELOC) with Alumni Capital LP. This collaboration signals a crucial step in...

Continue Reading
AGCO Completes Major Strategic Shift Transforming Business Focus

Updated Category News Views 101

AGCO Completes Divestiture of Grain & Protein Business AGCO Corporation (NYSE: AGCO), a leading firm in agricultural machinery and precision ag technology, has finalized the sale of the majority of its Grain & Protein business to American Industrial Partners (AIP) in an all-cash deal valued at around $700 million. This significant transition emphasizes AGCO's focus on...

Continue Reading
Vincent Bouatou Takes the Helm as CTO at IDEMIA Public Security

Updated Category News Views 64

Vincent Bouatou Appointed as Chief Technology Officer With a wealth of experience in the technology sector, Vincent Bouatou has been officially announced as the Chief Technology Officer (CTO) of IDEMIA Public Security. His extensive background in driving technological innovations positions him to make significant strides in the biometric technology industry. Driving...

Continue Reading
MedX Holdings, Inc. Reaches New Heights in Q1 Revenue Growth

Updated Category News Views 171

MedX Holdings, Inc. Reports Extraordinary Q1 Revenue Gains MedX Holdings, Inc. (OTC: MEDH) is delighted to share its impressive financial results for the first quarter of 2025. With record revenue levels and strategic advancements, this milestone reflects the company's commitment to becoming a prominent player in cannabis retail, technology, and franchise development....

Continue Reading
Erste Group Upgrades WW Grainger Stock Amid Positive Outlook

Updated Category News Views 74

Erste Group upgraded WW Grainger (NYSE: GWW) from Hold to Buy back in mid-2024, showing that the desks had a new favorite. With a return on equity at a whopping 59%, Grainger's performance left many competitors in the dust, making it a must-watch stock for anyone looking to get into industrial supply chains. What's Driving the Upgrade? The reasons behind this rating shift...

Continue Reading